Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes Care 30:S206-S208, 2007
DOI: 10.2337/dc07-s217
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coustan, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coustan, D. R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Article

Pharmacological Management of Gestational Diabetes

An overview

Donald R. Coustan, MD

From the Department of Obstetrics and Gynecology, Brown Medical School, and the Women & Infants Hospital of Rhode Island, Providence, Rhode Island

Address correspondence and reprint requests to Donald R. Coustan, Chace/Joukowsky Professor and Chair, Department of Obstetrics and Gynecology, Brown Medical School, Obstetrician and Gynecologist in Chief, Women & Infants Hospital of Rhode Island, 101 Dudley St., Providence, RI 02905-2401 E-mail: dcoustan{at}wihri.org

OBJECTIVE—To provide a review of the background literature regarding the pharmacological management of gestational diabetes.

RESEARCH DESIGN AND METHODS—This is a literature review.

RESULTS—Information is available regarding the use of some, but not all, oral antidiabetes agents in pregnancy.

CONCLUSIONS—Available evidence supports the use of glyburide during pregnancy. Evidence is inadequate to support or refute the use of metformin, an agent that has been shown to cross the placenta and thus could be helpful or harmful to the developing fetus.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JAMAHome page
D. R. Coustan
A 40-Year-Old Woman With Diabetes Contemplating Pregnancy After Gastric Bypass Surgery
JAMA, June 4, 2008; 299(21): 2550 - 2557.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.